Cargando…
The possibility of lapatinib treatment for breast cancer patients with central nervous system metastases. Case study and literature review
In patients with breast cancer with overexpression of the HER2 receptor, during treatment with trastuzumab, in 30% of cases brain metastases are observed. The use of lapatinib with capecitabine (L + C) seems to be an efficacious method of curing patients in whom the spread of cancer in this location...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687474/ https://www.ncbi.nlm.nih.gov/pubmed/23788948 http://dx.doi.org/10.5114/wo.2012.32494 |